Cybin Inc. Form 6-K Summary
Business Context and Reporting Period
Cybin Inc., a foreign private issuer, filed this Form 6-K for the month of April 2024. The filing was signed on April 18, 2024, by Chief Executive Officer Doug Drysdale.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
The filing does not describe operating or financial changes versus a prior comparable period.
Guidance, Risks, and Unusual Items
The filing contains no guidance, outlook, management commentary, risk disclosures, contingencies, or unusual financial items. Its substantive content is the filing of Exhibit 99.1, a consent from Aird & Berlis LLP.
Exhibit 99.1 is incorporated by reference into Cybin’s Registration Statements on Form F-10, File Nos. 333-272706 and 333-276333, as amended or supplemented.
Investor Verification Items
- Review Exhibit 99.1 to confirm the scope and purpose of the legal consent.
- Review the referenced Form F-10 registration statements for the related offering and securities information.
- Use a subsequent periodic filing to verify Cybin’s financial condition, liquidity, operating results, and clinical-program developments.